内部人交易记录
董事基于 6 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the complete record of transactions filed by Nielsen Kirk G., 董事. Director active across 3 companies, notably Inari Medical, Inc.. Cumulatively, 15 reports have been logged. Breakdown: 8 buys · 0 sell. Total volume traded: €650k. History available since 27 May 2021. The latest transaction was disclosed on 1 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Nielsen Kirk G.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
8,720 股0Common StockSEC:0001523522-26-000007:0
1,690,230 股Common StockSEC:0001193125-26-045029:0
10,966 股@ US$5.45288.2% 占其流量Common StockSEC:0000950170-25-074682:0
25,200 股@ US$4.788516.7% 占其流量Common StockSEC:0000950170-25-071629:0
2,982 股0Common StockSEC:0001127602-23-017037:0
2,412 股0Common StockSEC:0001127602-23-016392:0
2,420 股0Common StockSEC:0001127602-22-015870:0
8,070 股@ US$5.04980.020% mcap7.8% 占其流量Common StockSEC:0000899243-22-019805:0
10,976 股@ US$5.0380.028% mcap10.7% 占其流量Common StockSEC:0000899243-22-019287:0
32,809 股@ US$5.99720.10% mcap38.3% 占其流量Common StockSEC:0000899243-22-016823:0
100 股@ US$5.970.0003% mcap0.1% 占其流量Common StockSEC:0000899243-22-016135:0
3,400 股@ US$8.23813.8% 占其流量Common StockSEC:0000899243-22-008108:0
26,659 股@ US$7.923328.6% 占其流量Common StockSEC:0000899243-22-007418:0
1,461,831 股Common StockSEC:0001179110-21-007340:0
2,982 股0Common StockSEC:0001562180-21-003847:0
About Nielsen Kirk G.
Nielsen Kirk G. is Director of CVRx, Inc., Inari Medical, Inc. and SpyGlass Pharma, Inc. The 15 filings recorded, all of the available sampled filings, cover the period from 2021-05-28 to 2026-06-03, with EUR 650467 of purchases and EUR 0 of sales, and the modal transaction nature is Acquisition.